• 1. Evidence that the availability of an allylic hydrogen governs the regioselectivity of the Wacker oxidation
  Matthew J. Gaunt,Jinquan Yu,Jonathan B. Spencer Chem. Commun., 2001, 1844-1845
• 2. Emergence of microfluidic wearable technologies
  Joo Chuan Yeo,Kenry Lab Chip, 2016,16, 4082-4090
• 3. Esterase-responsive polymeric prodrug-based tumor targeting nanoparticles for improved anti-tumor performance against colon cancer?
  Gang Pan,Yi-jie Bao,Jie Xu,Tao Liu,Cheng Liu,Yan-yan Qiu,Xiao-jing Shi,Hui Yu,Ting-ting Jia,Xia Yuan,Ze-ting Yuan,Yi-jun Cao RSC Adv., 2016,6, 42109-42119
• 4. Excimer emission and magnetoluminescence of radical-based zinc(ii) complexes doped in host crystals?
  Shojiro Kimura,Tetsuro Kusamoto Chem. Commun., 2020,56, 11195-11198
• 5. Emerging investigator series: heterogeneous reactions of sulfur dioxide on mineral dust nanoparticles: from single component to mixed components?
  Tao Wang,Yangyang Liu,Yue Deng,Hongbo Fu,Jianmin Chen Environ. Sci.: Nano, 2018,5, 1821-1833

• Solvents and Organic Chemicals Organic Compounds Benzenoids Benzene and substituted derivatives Benzyl cyanides
• Solvents and Organic Chemicals Organic Compounds cyanides/Cyanides

Research Brief on 2-Chloro-6-fluorophenylacetonitrile (CAS: 75279-55-9): Recent Advances and Applications in Chemical Biology and Pharmaceutical Sciences

2-Chloro-6-fluorophenylacetonitrile (CAS: 75279-55-9) is a key intermediate in the synthesis of various bioactive molecules, particularly in the development of pharmaceuticals and agrochemicals. Recent studies have highlighted its significance in the construction of heterocyclic compounds, which serve as scaffolds for drug discovery. This research brief consolidates the latest findings on the synthesis, applications, and mechanistic insights of this compound, providing a comprehensive overview for researchers in the field.

In a 2023 study published in the Journal of Medicinal Chemistry, researchers explored the use of 2-Chloro-6-fluorophenylacetonitrile as a precursor for the synthesis of novel kinase inhibitors. The study demonstrated that the compound's unique halogenated structure facilitates selective binding to ATP pockets in target kinases, offering potential therapeutic avenues for cancer treatment. The research team employed a combination of computational docking and in vitro assays to validate the compound's efficacy, revealing promising inhibitory activity against EGFR and VEGFR2 kinases.

Another significant advancement was reported in Organic Letters, where 2-Chloro-6-fluorophenylacetonitrile was utilized in a palladium-catalyzed cyanation reaction to produce high-value fluorinated aromatic nitriles. The study emphasized the compound's role in enabling C–C bond formation under mild conditions, which is critical for the sustainable synthesis of complex molecules. The methodology presented in this work has been adopted by several pharmaceutical companies for the scalable production of intermediates.

Recent patent filings (e.g., WO2023056123) have also highlighted the compound's utility in agrochemical applications. Specifically, derivatives of 2-Chloro-6-fluorophenylacetonitrile have shown potent herbicidal activity against resistant weed species, addressing a growing challenge in agricultural productivity. The patents describe novel formulations that enhance the compound's stability and bioavailability in field conditions.

In conclusion, 2-Chloro-6-fluorophenylacetonitrile (CAS: 75279-55-9) continues to be a versatile building block in chemical biology and pharmaceutical research. Its applications span from drug discovery to agrochemical development, driven by its unique structural and reactivity properties. Future research directions may focus on expanding its utility in green chemistry protocols and exploring its potential in emerging therapeutic areas such as neurodegenerative diseases.

• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)